Celgene is a top pharmaceutical company, incorporated in Delaware and headquartered in Summit, New Jersey
German healthcare group Merck KGaA is looking for acquisitions and collaborations with start-ups to grow its drugs business in the United States, a senior Merck official said.
M&A: Would you rather be smart or lucky?
The first six months of 2012 have been busy for life science dealmakers, with significant partnerships across numerous therapy areas
Welcome to the March 2012 edition of Current Agreements Deal Analysis Update
The week was relatively quiet until the end of week announcement by Merck KGaA of a $550 million partnership with Threshold for the co-development and commercialization of TH-302
Pfizer is a top pharma company active in partnering, licensing and M&A in pharmaceuticals
Sorry, your search returned no results.
Aduro Biotech announced the closing of a $51.4 million Series D preferred stock financing
Bristol-Myers Squibb and Five Prime Therapeutics have entered into an exclusive clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining Opdivo (nivolumab), Bristol-Myers Squibb’s investigational PD-1 (programmed death-1) immune checkpoint inhibitor, with FPA008
MacroGenics and Takeda Pharmaceutical announced inking a pharma licensing deal to develop and commercialize four potential product candidates.